SantoshKesariMDPhD, FANA, FAAN

Neurology • Santa Monica, CA

Neurooncology

Pacific Neuroscience Institute/ Saint John's Cancer Institute

Join to view full profile

Dr. Kesari is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kesari's full profile

Already have an account?

Office
Saint John's Cancer Institute at Providence Saint John’s Health Center
2200 Santa Monica Blvd.
Santa Monica, CA 90404
Phone+1 310-829-8265

Fax+1 310-582-7287

Summary

Dr. Santosh Kesari is a board-certified neurologist and neuro-oncologist and is currently Chair, Department of Neurosciences and Neurotherapeutics, John Wayne Cancer Institute and Pacific Neuroscience Institute. He is also Director of Neuro-Oncology, Providence Saint John’s Health Center and Member, Los Angeles Biomedical Research Institute. Dr. Kesari is ranked among the top 1% of neuro-oncologists and neurologists in the nation, according to Castle Connolly Medical Ltd and an internationally recognized scientist and clinician. He is a winner of an Innovation Award by the San Diego Business Journal. He is on the advisory board of American Brain Tumor Association, San Diego Brain Tumor Foundation, Chris Elliott Fund, Nicolas Conor Institute, Voices Against Brain Cancer, and Philippine Brain Tumor Alliance. He has been the author of over 250 scientific publications, reviews, or books. He is the inventor on several patents and patent applications, and founder and advisor to many cancer and neurosciences focused biotech startups.

Dr. Kesari graduated from University of Pennsylvania, School of Arts and Sciences in 1992 and earned a Ph.D. degree in molecular biology and a M.D. from the University of Pennsylvania, School of Medicine. He completed his residency in neurology at the Massachusetts General Hospital/Brigham and Women’s Hospital/Harvard Medical School and his neuro-oncology fellowship at the Dana-Farber Cancer Institute in Boston. He was previously assistant professor of neurology at Harvard Medical School/Dana-Farber Cancer Institute/Brigham and Women’s Hospital and then professor of neurosciences at UC San Diego. He is a member of the Society of Neuro-Oncology, American Society of Clinical Oncology, Indian Society of Neuro-Oncology, American Neurological Association, and American Academy of Neurology. For information about Dr. Kesari's research, go to http://www.pacificneuroscienceinstitute.org/people/santosh-kesari-md-phd/.

Education & Training

Dana-Farber Cancer InstituteFellowship, Cancer Biology, 2004 - 2006
Massachusetts Gen Hosp2003 - 2006
Dana-Farber Cancer Institute/BWH/MGH2003 - 2004
Harvard School of Public HealthProgram, Clinical Effectiveness, 2004
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2000 - 2003
Harvard Medical School2000 - 2003
Beth Israel Deaconess Medical Center/Harvard Medical SchoolInternship, Neurology, 1999 - 2000
Brigham and Women's HospitalFellowship, Internal Medicine, 1999 - 2000
Perelman School of Medicine at the University of PennsylvaniaClass of 1999, MD
National Hospital for Neurology and NeurosurgeryExtern, 1999
University of Pennsylvania School of MedicinePh.D, Molecular Biology, 1993 - 1996
University of Pennsylvania, College of Arts and SciencesBA, Biology and Mathematics, 1989
George Washington High SchoolHS, 1989

Certifications & Licensure

CA State Medical License 2009 - 2025
MA State Medical License 2001 - 2010
National Board of Physicians and Surgeons Neurology
United Council for Neurologic SubspecialtiesNeuro-Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2012-2014
Top Doctors:San Diego Area Castle Connolly, 2013
America's Top Doctors for Cancer Castle Connolly, 2011-2013
Castle Connolly Top Doctors: Southern California Castle Connolly, 2012
Innovation Awards, Medical Research, San Diego Business Journal San Deigo Business Journal, 2012
Top Doctors:Southern California Castle Connolly, 2012
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Finalist, Health Care Champions Award, Health Technology Innovations and Research San Diego Business Journal, 2011
U.S. News Top Doctors in Medical Oncology U.S. News, 2011
Doc Star (Cancer) Geoffrey Beene Rock Stars of Science, 2011
Best Doctors in America Best Doctors, 2010
Overseas Executive Chairman, Chongqing International Neurological Forum Chongqing Association for Science and Technology, Chongqing, China, 2010
Marquis Who's Who in America 2007-2009, 2009
Gold Doc Award Arnold P. Gold Foundation, 2009
Marquis Who's Who in Science and Engineering 2008
Global Directory of Who's Who 2008
Sontag Foundation Distinguished Scientist Award 2006
Sontag Foundation Distinguished Scientist Award Sontag Foundation, 2006
Founders Award American Academy of Neurology, 2003
American Neurological Association Travel Award 2002
Dr. William A. Jeffers Prize, University of Pennsylvania 1995, 1996
American Society for Virology Student Travel Award 1995
NIH National Research Service Award 1994
Pi Mu Epsilon National Mathematics Honor Society 1991
Benjamin Franklin Scholar University of Pennsylvania, 1991
Penn Medical Scholar University of Pennsylvania, 1990
Join now to see all

Clinical Trials

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01
Active, not recruiting
Phase 3
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Start of enrollment: 2008 Sep 01
Completed
Phase 2
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Start of enrollment: 2009 Jun 01
Completed
Phase 3
Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer Start of enrollment: 2011 Apr 01
Completed
Phase 2
Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas Start of enrollment: 2010 Apr 21
Completed
Phase 2
A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma Start of enrollment: 2010 Jul 01
Completed
Phase 1
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM) Start of enrollment: 2011 Jan 01
Completed
Phase 2
Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor Start of enrollment: 2012 Feb 01
Completed
Phase 1
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2011 Nov 01
Completed
Phase 3
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases Start of enrollment: 2011 Oct 01
Completed
Phase 2
GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L) Start of enrollment: 2011 Nov 01
Terminated
Phase 2
Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM) Start of enrollment: 2012 Jun 19
Terminated
Phase 2
Dexanabinol in Patients With Brain Cancer Start of enrollment: 2012 Jun 01
Completed
Phase 1
Post-approval Study of NovoTTF-100A in Recurrent GBM Patients Start of enrollment: 2012 Dec 01
Terminated
Phase 4
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma Start of enrollment: 2013 Jun 01
Completed
Phase 3
BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM) Start of enrollment: 2013 May 01
Completed
Phase 2
ANG1005 in Patients With Recurrent High-Grade Glioma Start of enrollment: 2013 Oct 01
Completed
Phase 2
Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma Start of enrollment: 2014 Feb 01
Completed
Phase 2
Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast Cancer Start of enrollment: 2014 May 01
Terminated
Phase 1, Phase 2
An Exploratory Study of Caregiver Burden Among Family Caregivers of Patients With Cancer Start of enrollment: 2017 Feb 23
Completed
Evaluation of a Mobile Digital Solution for Cancer Care and Research Start of enrollment: 2017 Apr 01
Completed
Not Applicable
Mitigating Cephalad Fluid Shifts: A NSBRI Study Start of enrollment: 2017 Jan 01
Completed
Not Applicable
CancerLife: Patient-Driven Solution in Cancer Care Start of enrollment: 2018 Mar 15
Completed
Not Applicable
A Longitudinal Assessment of Tumor Evolution in Patients With Brain Cancer Start of enrollment: 2018 Mar 01
Completed
Phase 1
Memantine XR and Pregabalin for Chemotherapy-Induced Peripheral Neuropathy Start of enrollment: 2016 Jul 09
Completed
Pemetrexed for the Treatment of Chordoma Start of enrollment: 2019 Sep 06
Completed
Phase 1
Pilot Study of Neoantigen Peptides for the Treatment of Neoplasms Start of enrollment: 2020 Aug 10
Completed
Early Phase 1
Join now to see all

Publications & Presentations

PubMed

Pre-radiation Nivolumab plus ipilimumab in patients with newly diagnosed high-grade gliomas.
Santosh Kesari, Alexandre Wojcinski, Sarabjot Pabla, R J Seager, Jaya M Gill
Oncoimmunology. 2024-12-31
Neoadjuvant clinical trials in adults with newly diagnosed high-grade glioma: A systematic review.
Tiffany M Juarez, Jaya M Gill, Boris R Minev, Akanksha Sharma, Santosh Kesari
Critical Reviews in Oncology/hematology. 2024-12-13
Proton pump inhibitors are detrimental to overall survival of patients with glioblastoma: Results from a nationwide real-world evidence database.
Michael P Castro, Jameson Quinn, Asher Wasserman, Alaa Awawda, Zachariah D Cole
Neuro-Oncology Practice. 2024-12-01

Journal Articles

Fibroblasts as a Practical Alternative to Mesenchymal Stem Cells
Santosh Kesari, MD, BioMed Central
Pritumumab, the First Therapeutic Antibody for Glioma Patients
Santosh Kesari, MD, Journal of Pediatric Rehabilitation Medicine
Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant.
Randazzo BP, Kesari S, Gesser RM, Alsop D, Ford JC, Brown SM, MacLean AR, Fraser NW, Virology; 211(1):94-101
Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant.
Kesari S, Randazzo BP, Nagy T, Huang QS, Brown SM, MacLean AR, Lee VM, Trojanowski JQ, Fraser NW, Laboratory Investigation; 73(5):636-48
Selective vulnerability of mouse CNS neurons to latent infection with a neuroattenuated herpes simplex virus-1.
Kesari S, Lee VM, Brown SM, Trojanowski JQ, Fraser NW, Journal of Neuroscience; 16(18):5644-53
Increased susceptibility to the pathogenic effects of wild-type and recombinant herpesviruses in MPS VII mice compared to normal siblings.
Wolfe JH, Martin CE, Deshmane SL, Reilly JJ, Kesari S, Fraser NW, Journal of Neurovirology; 2(6):417-22
Therapy of a murine model of pediatric brain tumors using a herpes simplex virus type-1 ICP34.5 mutant and demonstration of viral replication within the CNS.
Lasner TM, Kesari S, Brown SM, Lee VM, Fraser NW, Trojanowski JQ, Journal of Neuropathology and Experimental Neurology; 55(12):1259-69
Treatment of experimental subcutaneous human melanoma with a replication-restricted herpes simplex virus mutant.
Randazzo BP, Bhat MG, Kesari S, Fraser NW, Brown SM, Journal of Investigative Dermatology;108(6):933-7
Beta-gal enzyme activity driven by the HSV LAT promoter does not correspond to Beta-gal RNA levels in mouse trigeminal ganglia.
Huang QS, Nagy T, Kesari S, Fraser NW, Gene Therapy; 4(8):797-807
Herpes simplex virus 1716, an ICP34.5 null mutant, is unable to replicate in CV-1 cells due to a translational block that can be overcome by coinfection with SV40.
Randazzo BP, Tal-Singer R, Zabolotny JM, Kesari S, Fraser NW, Journal of General Virology; 78(12):3333-9
A neuroattenuated ICP34.5-deficient herpes simplex virus type 1 replicates in ependymal cells of the murine central nervous system.
Kesari S, Lasner TM, Balsara KR, Randazzo BP, Lee VM, Trojanowski JQ, Fraser NW, Journal of General Virology; 79(3):525-36
Toxicity and neuronal infection of a HSV-1 ICP34.5 mutant in nude mice.
Lasner TM, Tal-Singer R, Kesari S, Lee VM, Trojanowski JQ, Fraser NW, Journal of Neurovirology; 3(1):100-5
Infection and establishment of latency in the dog brain after direct inoculation of a nonpathogenic strain of herpes simplex virus-1.
Springer SL, Vite CH, Polesky AC, Kesari S, Fraser NW, Wolfe JH, Journal of Neurovirology; 7(2):149-54
Comparison of linear and volumetric criteria in assessing tumor response in adult high grade gliomas.
Shah G, Kesari S, Xu RH, Batchelor TT, O’Neill AM, Hochberg FH, Levy B, Bradshaw J, Wen PY, Neuro-Oncology; 8(1):38-46
Development of NG2 neural progenitor cells requires Olig gene function.
Ligon KL, Kesari S, Kitada M, Sun T, Arnett HA, Alberta JA, Anderson DJ, Stiles CD, Rowitch DH, Proceedings of the National Academy of Sciences;103(20):7853-58
Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: Co-localization of CD8+ T cells with JCV-infected glial cells.
Wüthrich C, Kesari S, Kim W-K, Williams K, Gelman R, Elmeric D, De Girolami U, Joseph JT, Hedley-Whyte T, Koralnik IJ, Journal of Neurovirology; 12(2):116-28
Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas.
Doherty L, Gigas DC, Kesari S, Drappatz J, Kim R, Zimmerman J, Ostrowsky L, Wen PY, Neurology; 67(1):156-8
Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose ...
Jackman DM, Holmes AJ, Lindeman N, Wen PY, Kesari S, Borras AM, Bailey C, de Jong F, Jänne PA, Johnson BE, Journal of Clinical Oncology; 24(27):4517-20
Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients.
Khwaja FW, Reed MS, Olson JJ, Schmotzer BJ, Gillespie GY, Guha A, Groves MD, Kesari S, Pohl J, Van Meir EG, Journal of Proteome Research; 6(2):559-70
Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma.
Ligon KL, Huillard E, Mehta S, Kesari S, Liu H, Alberta JA, Bachoo RM, Kane M, Louis DN, DePinho RA, Anderson DJ, Stiles CD, Rowitch DH, Neuron; 53(4):503-17
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
19. Kesari S, Schiff D, Doherty L, Gigas DC, Batchelor TT, Muzikansky A, O’Neill A, Drappatz J, Chen-Plotkin AS, Ramakrishna N, Weiss SE, Levy B, Bradshaw J, Kracher J..., Neuro-Oncology; 9(3): 354-63
Chemically-selective imaging of brain structures with CARS microscopy.
Evans CL, Xu X, Kesari S, Xie XS, Wong STC, Young GS, Optics Express; 15(19):12076-87
Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence.
Norden AD, Young GS, Setayesh K, Muzikansky A, Kulfas R, Ross GL, Ciampa AS, Ebbeling LG, Levy B, Drappatz J, Kesari S, Wen PY, Neurology; 70:779-87
Prognostic factors in adult brainstem gliomas: A multicenter, retrospective analysis of 101 cases.
Kesari S*, Kim RS, Markos V, Drappatz J, Wen PY, Pruitt AA, Journal of Neuro-Oncology; 88(2):175-83
Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults.
Kesari S, Schiff D, Henson JW, Muzikansky A, Gigas DC, Doherty L, Batchelor TT, Longtine JA, Ligon KL, Weaver S, Laforme A, Ramakrishna N, Black PM, Drappatz J, Ciampa..., Neuro-Oncology; 10(3):300-8
Join now to see all

Books/Book Chapters

MedLink Neurology.
Chapter: Leptomeningeal metastases
Grewal J, Kesari SEditors: Gilman S.MedLink Corporation (www.medlink.com), San Diego
Hospital physician oncology ?board review manual.
Chapter: Metastatic brain tumors (Chap. 13)
Grewal J, Grewal HK, Kesari SEditors: Skarin A.Turner White Communications, Wayne, PA
Hospital physician oncology ?board review manual.
Chapter: Primary brain tumors (Chap. 13)
Grewal J, Grewal HK, Kesari SEditors: Skarin A.Turner White Communications, Wayne, PA
Hospital physician neurology board review manual.
Chapter: Cancer neurology: Primary CNS lymphoma, paraneoplastic syndromes, and pituitary adenoma (Chap. 11, Pt 1)
Page 1 - 16Norden AD, Kesari SEditors: Atri A, Milligan TA.Turner White Communications, Wayne, PA
Hospital physician neurology board review manual.
Chapter: Cancer neurology: Primary and metastatic brain tumors (Chapter 10, Pt 3)
Page 1 - 16Norden AD, Kesari SEditors: Atri A, Milligan TA.Turner White Communications, Wayne, PA
Merck & Co. Monographs in Medicine: A Study of Migraine.
Chapter: Digitally altered photographs depicting different manifestations of visual aura
Kesari SWhitehouse Station, New Jersey
Neurologic Complications of Cancer Therapy.
Chapter: Neurological complications of corticosteroids in cancer therapy
Dunbar EM, Kalani R, Kesari SEditors: Quant E, Schiff D, Wen PY.Demos Medical Publishing
Neuro-oncology.
Chapter: General aspects of chemotherapy
Hu J, Kesari SEditors: Schiff D.Wiley-Blackwell, St. LouisEdition 1,
Adult Neuro-oncology: A Multidisciplinary, Evidence-Based Approach with Case Studies.
Chapter: Abnormalities of gait
Cibula J, Kesari S, Dunbar EMEditors: Jeyaplan S, Kasper E, Mahadevan A.Springer, St. Louis
Adult Neuro-oncology: A Multidisciplinary, Evidence-Based Approach with Case Studies.
Chapter: Systemic therapy for cancer of the nervous system
Mahta A, Kesari SEditors: Jeyaplan S, Kasper E, Mahadevan A.Springer, St. LouisEdition 1,
Adult Neuro-oncology: A Multidisciplinary, Evidence-Based Approach with Case Studies.
Chapter: Medical management of neurological cancers
Aenlle L, Dunbar E, Kesari SEditors: Jeyaplan S, Kasper E, Mahadevan A.Springer, St. LouisEdition 1,
Key Principles in Glioblastoma Therapy. Advances in the Biology, Imaging and Therapies for Glioblastoma.
Jiri B Jr., Ng K, Jiri B Sr., Kesari S, Carter B, Chen CCEditors: Clark C. Chen.InTech (http://www.intechopen.com/articles/show/title/key-principles-in-glioblastoma-therapy)
DNA Damage Response and Repair: Insights into Strategies for Radiation Sensitization, Selected Topics in DNA Repair.
Lawson JD, Kahle KT, Ng K, Carter B, Kesari S, Chen CCEditors: Clark C. Chen.InTech (http://www.intechopen.com/articles/show/title/...)
Molecular Etiology of Glioblastomas: Implication of Genomic Profiling From the Cancer Genome Atlas Project, Glioma-Exploring Its Biology and Practical Relevance.
Ng K, Kesari S, Carter B, Chen CCEditors: Anirban Ghosh.InTech (http://www.intechopen.com/articles/show/title/...)
Glioma stem cells, Cancer Stem Cells-The Cutting Edge.
Kim RY, Mahta A, Kesari SInTech (http://www.intechopen.com/articles/show/title/glioma-stem-cells)
Samuel’s Manual of Neurologic Therapeutics.
Chapter: Neurooncology
Page 114 - 170Kesari S, Wen PYEditors: Samuels MA, Ropper A.Lippincott Williams & Wilkins, PhiladelphiaEdition 8,
MedLink Neurology.
Chapter: Neurologic complications of chemotherapy
Wen PY, Kesari SEditors: Gilman S.www.medlink.com
MedLink Neurology.
Chapter: Sequelae of treatments of CNS tumors
Grewal J, Kesari SEditors: Gilman S.MedLink Corporation (www.medlink.com), San Diego
MedLink Neurology.
Chapter: Spinal astrocytoma
Grewal J, Grewal HK, Kesari SEditors: Gilman S.MedLink Corporation (www.medlink.com), San Diego
MedLink Neurology.
Chapter: Cerebrovascular complications of cancer
Grewal J, Grewal HK, Kesari SEditors: Gilman S.MedLink Corporation (www.medlink.com), San Diego
MedLink Neurology.
Chapter: Primary central nervous system lymphoma
Grewal J, Kesari SEditors: Gilman S.MedLink Corporation (www.medlink.com), San Diego
Decision making in medicine: An algorithmic approach.
Chapter: Disturbances of smell and taste
Page 458 - 459Kesari SEditors: Mushlin S, Greene HL.Mosby, St. LouisEdition 3,
Decision making in medicine: An algorithmic approach.
Chapter: Chronic headache
Page 403 - 407Kesari SEditors: Mushlin S, Greene HL.Mosby, St. LouisEdition 3,
Decision making in medicine: An algorithmic approach.
Chapter: Acute headache
Page 402 - 403Kesari SEditors: Mushlin S, Greene HL.Mosby, St. LouisEdition 3,
Late Effects of Treatment for Brain Tumors.
Chapter: Effect of cancer treatment on neural stem and progenitor cells
Page 81 - 95Dietrich J, Kesari SEditors: Goldman S and Turner CD.
Join now to see all

Lectures

Advances in the Management of Recurrent Glioblastoma.
Lehigh Valley Hospital, Allentown, Pennsylvania
Progress in Neuro-Oncology.
Oregon Health & Science University, Portland, Oregon
Clinical and Molecular Heterogeneity in Brain Cancers.
Arizona State University, Phoenix, Arizona
Neuro-Oncology: Biomarker Discovery and Individualized Therapies.
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Genes and Oncology Research.
San Diego, CA
Translating lessons from adult malignant brain tumors to neurofibromatosis research.
Children’s Tumor Foundation, New York, New York
Lymphomatous Meningitis and Advances in Glioma Therapies.
University of Louisville, Louisville, Kentucky
Therapy Considerations in Lymphomatous Meningitis.
Saint Michael’s Medical Center, Newark, New Jersey
Biological and Therapeutic Advances in Neuro-Oncology.
Vanderbilt University, Nashville, Tennessee
Scientific and Clinical Advances in Neuro-Oncology.
University of North Carolina, North Carolina
Update on Olig2 and Discovering Biomarkers of Treatment Response in Glioblastoma.
Amelia Island, Florida
Improving Outcomes in Neuro-Oncology: Tumor Heterogeneity and Targeted Therapies.
University of Washington Medical Center, Seattle, Washington
Stem Cells, Gliomagenesis, and Neoplastic Meningitis: Opportunities for Personalized Therapies.
University of Virginia, Charlottesville, Virginia
Neuro-Oncology: At the Crossroads of Neuroscience.
University of California, San Diego, California
Recent Progress in Neuro-Oncology.
Medical University of South Carolina, Charleston, South Carolina
Olig2 and translational explorations in gliomas.
Memorial Sloan Kettering Cancer Center, New York, New York
Translational Studies in Neuro-Oncology.
University of Utah, Department of Neurology, Salt Lake City, Utah
Olig2 and Cell Cycle Regulation in Glioblastoma.
University of Utah, School of Medicine, Salt Lake City, Utah
Olig2-P53 Signaling Axis in Glioblastoma.
Jacksonsville, Florida
Translational Studies in Gliomas.
University of Nebraska Medical Center, Omaha, Nebraska
Stem Cells and Brain Tumors: New Research Perspectives.
University of Texas, Memorial Hermann Hospital, Houston, Texas
Advances in Neuro-Oncology.
University of Texas, Memorial Hermann Hospital, Houston, Texas
Emerging Management Strategies for Malignant Gliomas.
Mumbai, India
Standard of Care in Glioblastoma.
Nanjing City, China
Where are we with targeted molecular therapy.
Kolkata, India
Join now to see all

Other

Systems and Methods for Internal Organ Mico-imaging in situ using scanning fiber-optic microscopes.
Santosh Kesari, BWH
Small Molecule Microarrays and Methods for Making and Using them.
Shu Chein, Dayu Teng, Santosh Kesari, Pengfei Jiang, UCSD SD2011-024 (provisional patent 61/375,373, filed 8/20/10)
Diagnosing CNS Malignancies Using MicroRNA.
Anna M. Krichevsky, Brit Mollenhauer, Nadiya M Teplyuk, Santosh Kesari
Efficient Intraliposomal Encapsulation of Active Pharmaceutical Ingredients.
Santosh Kesari, Rajesh Mukthavaram, Milan Makale, Wolf Wrasidlo, UCSD SD2012-176-1, U.S. Provisional Application Serial No. 61/ 569,146
New Drug Combination and Usage for Cancer Therapy.
Santosh Kesari, Pengfei Jiang, UCSD SD2012-231-1, U.S. Provisional Application Serial No. xxx
Join now to see all

Press Mentions

ALS Treatment: FDA to Rule on Drug Tofersen for Specific Type of the DiseaseApril 19th, 2023
Alzheimer's Disease: Modified mRNA Helps Reduce Symptoms in Mouse ModelMarch 14th, 2023
Why Some Cancer Tumors Can Become Resistant to ChemotherapyMarch 8th, 2023
Join now to see all